Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Managed Care & Specialty Pharmacy|July 16, 2024
Stakeholder perspectives on the sustainability of the United States biosimilars marketSean D Sullivan, Sophia Z Humphreys, David Fox, et al.Journal of the American Medical Informatics Association : JAMIA|September 12, 2022
The US Food and Drug Administration Sentinel System: a national resource for a learning health systemJeffrey S Brown, Aaron B Mendelsohn, Young Hee Nam, et al.Pharmacoepidemiology and Drug Safety|July 13, 2019
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilarsRishi J Desai, Seoyoung C Kim, Jeffrey R Curtis, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar SurveillanceJie Zhang, Gayathri Sridhar, Charles E Barr, et al.Journal of Medical Economics|March 8, 2023
Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithmCatherine M Lockhart, Cara L McDermott, Aaron B Mendelsohn, et al.Journal of Managed Care & Specialty Pharmacy|September 25, 2024
Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United StatesXiaodan Mai, Aaron B Mendelsohn, James Marshall, et al.Pharmacoepidemiology and Drug Safety|December 6, 2019
Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claimsJie Zhang, Kevin Haynes, Aaron B Mendelsohn, et al.Pageof 3